Selective breeding of farmed salmon has created significant welfare trade-offs between rapid growth and health, requiring careful genetic management for welfare outcomes.
The genetics of farmed Atlantic salmon represent decades of selection focused primarily on growth rate, with welfare consequences that are only now being systematically addressed. Fast-growing strains experience higher rates of skeletal deformities, eye pathologies, and early maturation — all welfare costs of selection pressure divorced from natural health constraints. The welfare-positive direction for salmon genetics includes explicit welfare traits in selection indices, breeding for disease resistance alongside growth, and reducing the physiological consequences of growth rates that outpace musculoskeletal and physiological development. This requires breeding companies to invest in welfare outcome measurement and include welfare metrics in breeding objectives rather than treating them as by-products of productivity selection.